Hajeong Lee

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo

Seong‐Hae Jeong, Ji‐Soo Kim, Jong Wook Shin et al. · Journal of Neurology · 2012 · 178 citations

Serum Vitamin D

Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, <scp>EVIDENCE</scp>

Go Hun Seo, Tae Ho Kim, In Hee Choi et al. · Clinical Genetics · 2020 · 161 citations · Full text

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni et al. · Nature Genetics · 2023 · 156 citations · Full text

Genome-wide Association Study, Glomerulonephritis, Genome-wide Association +15